• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
DAWN

DAWN

Day One Biopharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD21.53

+0.00 (+0.00%)

Company Profile

CEO

Jeremy Bender

IPO Date

2021-05-27

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$21.53

Prev. Close

$21.53

Day Low

$21.53

Day High

$21.53

52W Low

$5.63

52W High

$21.53

Market Cap

$2.22B

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

6

Avg Positive

42.5%

Avg Negative

1.2%

Avg Neutral

56.0%

News Feed

Day One Appoints Scott Garland to Board of Directors

GlobeNewsWire·8/17/2021·↑ positive

Day One Reports Second Quarter 2021 Financial Results and Corporate Progress

GlobeNewsWire·8/10/2021·↑ positive

Day One Receives Orphan Designation from the European Commission for DAY101 for the Treatment of Glioma

GlobeNewsWire
·6/21/2021
·↑ positive

Day One Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·6/1/2021·↑ positive

Day One Announces Pricing of Upsized Initial Public Offering

GlobeNewsWire·5/26/2021·↑ positive

Day One Biopharmaceuticals upsizes IPO to 10 million shares from 8.4 million

Market Watch·5/26/2021·↑ positive